$ News

Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak

Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak

Theratechnologies Inc. (TH:CA) Special Meeting Of Shareholders Of Theratechnologies Call (Transcript)

Theratechnologies Launches New Tesamorelin Formulation in US After FDA Approval

Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy

Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak

Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak

Theratechnologies: Fiscal Q2 Earnings Snapshot

Theratechnologies Reports Financial Results for the Second Quarter 2025

Theratechnologies: Beyond GLP-1s - Is Tesamorelin's Exit A Sign Of New Metabolic Opportunities?

Nuevocor Strengthens Board with Appointment of Thierry Abribat

Theratechnologies to Announce Second Quarter 2025 Financial Results

Theratechnologies shares surge 25% amid $254m Future Pak takeover

Theratechnologies Up More Than 30% In US Premarket As To Be Bought By CB Biotechnology

Theratechnologies to Be Acquired by Future Pak Affiliate for Up to $254 Million

Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak

Theratechnologies Reports on its Annual Meeting of Shareholders

Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV

Is Theratechnologies Inc. (THTX) the Best Rising Penny Stock to Buy According to Analysts?

Theratechnologies: A High-Risk, High-Reward Speculation As Shares Trade At 39% Discount To Future Pak's $3.51-$4.50 Offer